Shandong Jincheng Pharmaceutical and Chemical Co Ltd Total Assets
Shandong Jincheng Pharmaceutical and Chemical Co Ltd total assets. Based on the latest financial reports, Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) holds total assets worth CN¥5.21 Billion CNY (≈ $762.53 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Shandong Jincheng Pharmaceutical and Che (300233) total market value for the company's overall valuation and market capitalisation.
Total Assets of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Total assets of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. This chart illustrates how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's total assets have evolved over time, based on quarterly financial data. See latest Shandong Jincheng Pharmaceutical and Che stock price today for real-time trading data and today's change.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd - Asset Composition Analysis
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Total Assets Breakdown (December 2025)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd total assets breakdown as of December 2025. Shandong Jincheng Pharmaceutical and Chemical Co Ltd's total assets of CN¥5.21 Billion consist of 40.2% current assets and 59.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.9% |
| Accounts Receivable | CN¥534.89 Million | 10.3% |
| Inventory | CN¥464.61 Million | 9.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥684.47 Million | 13.2% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 300233 current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Jincheng Pharmaceutical and Chemical Co Ltd's current assets represent 40.2% of total assets in 2025, a decrease from 58.4% in 2008.
- Cash Position: Cash and equivalents constituted 15.9% of total assets in 2025, down from 21.7% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 10.0% in 2008.
- Asset Diversification: The largest asset category is intangible assets at 13.2% of total assets.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Competitors by Total Assets
Key competitors of Shandong Jincheng Pharmaceutical and Chemical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Levima Advanced Materials Corp
SHE:003022
|
China | CN¥26.17 Billion |
|
Shenzhen Senior Technology Material Co Ltd
SHE:300568
|
China | CN¥25.67 Billion |
|
Guangdong Orient Zirconic Ind Sci & Tech Co Ltd
SHE:002167
|
China | CN¥2.29 Billion |
|
Darbond Technology Co. Ltd. A
SHG:688035
|
China | CN¥3.42 Billion |
|
Jiangsu Chengxing Phosph-Chemical Co Ltd
SHG:600078
|
China | CN¥5.21 Billion |
|
Lecron Energy Saving Materials
SHE:300343
|
China | CN¥2.73 Billion |
|
Yunnan Yunwei Co Ltd Class A
SHG:600725
|
China | CN¥353.34 Million |
|
Shaanxi Xinghua Chemistry Co Ltd
SHE:002109
|
China | CN¥10.67 Billion |
Shandong Jincheng Pharmaceutical and Chemical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 1.95 | 1.80 |
| Quick Ratio | 1.38 | 1.41 | 1.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥919.64 Million | CN¥1.06 Billion | CN¥935.72 Million |
Shandong Jincheng Pharmaceutical and Chemical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shandong Jincheng Pharmaceutical and Chemical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.40 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -7.4% |
| Total Assets | CN¥5.19 Billion |
| Market Capitalization | $640.37 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Jincheng Pharmaceutical and Chemical Co Ltd's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Shandong Jincheng Pharmaceutical and Chemical Co Ltd's assets decreased by 7.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
The table below shows the annual total assets of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.19 Billion ≈ $759.59 Million |
-7.39% |
| 2024-12-31 | CN¥5.60 Billion ≈ $820.19 Million |
-5.26% |
| 2023-12-31 | CN¥5.92 Billion ≈ $865.71 Million |
+1.54% |
| 2022-12-31 | CN¥5.83 Billion ≈ $852.54 Million |
+10.44% |
| 2021-12-31 | CN¥5.28 Billion ≈ $771.92 Million |
+5.50% |
| 2020-12-31 | CN¥5.00 Billion ≈ $731.67 Million |
-10.59% |
| 2019-12-31 | CN¥5.59 Billion ≈ $818.34 Million |
+5.78% |
| 2018-12-31 | CN¥5.29 Billion ≈ $773.60 Million |
+7.80% |
| 2017-12-31 | CN¥4.90 Billion ≈ $717.60 Million |
+117.29% |
| 2016-12-31 | CN¥2.26 Billion ≈ $330.25 Million |
+13.05% |
| 2015-12-31 | CN¥2.00 Billion ≈ $292.12 Million |
+11.82% |
| 2014-12-31 | CN¥1.79 Billion ≈ $261.24 Million |
+13.29% |
| 2013-12-31 | CN¥1.58 Billion ≈ $230.59 Million |
+7.21% |
| 2012-12-31 | CN¥1.47 Billion ≈ $215.08 Million |
+5.12% |
| 2011-12-31 | CN¥1.40 Billion ≈ $204.60 Million |
+45.96% |
| 2010-12-31 | CN¥957.95 Million ≈ $140.18 Million |
+38.32% |
| 2009-12-31 | CN¥692.56 Million ≈ $101.34 Million |
+10.61% |
| 2008-12-31 | CN¥626.16 Million ≈ $91.63 Million |
-- |
About Shandong Jincheng Pharmaceutical and Chemical Co Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.